Prostate cancer is the most common form of cancer among men in England, with cases surging among both men and women by 25 per ...

Jyong Biotech targets urinary disorders with a novel botanical pipeline, but clinical and liquidity risks temper near-term ...

The global statistics are terrifying. Prostate cancer is the fourth most common cancer in all populations, the second most ...

In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how ...

After Teddi Mellencamp shared her cancer had progressed earlier this year, she shared why she has felt “sicker” amid ...

With regard to the choice of bone-protecting agent, denosumab (Xgeva) improved bone density and reduced fracture risk in a ...

Pharmaceutical scientists, clinicians, nurses and pharmacists from the National University of Singapore (NUS) and National ...

Men on active surveillance for low- to intermediate-risk prostate cancer (PCa) have low risk for PCa-related mortality at a median follow-up of 18 years. However, a majority of men do progress and ...

Results of a study led by VHIO’s Prostate Cancer Group suggest that treatment with CDK4/6 inhibitors followed by senloytic ...

Ryan Seacrest is getting candid. Seacrest, 50, got emotional and teared up during a July 21 broadcast of “On Air With Ryan ...

American Idol' host Ryan Seacrest opened up about his father's prostate cancer journey during an emotional broadcast of 'On ...

Ryan Seacrest revealed his dad Gary Lee Seacrest's battle with prostate cancer, sharing an emotional story about his health ...